Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Idebenone: Phase IIa data

In a double-blind, Belgian Phase IIa trial in 21 patients aged 8-16, a 450 mg/day

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE